Synthace
Markus Gershater is a co-founder and chief scientific officer of Synthace and one of the UK’s leading visionaries for how we, as a society, can do better biology. Originally establishing Synthace as a synthetic biology company, he was struck with the conviction that so much potential progress is held back by tedious, one-dimensional, error-prone, manual work. Instead, what if we could lift the whole experimental cycle into the cloud and make software and machines carry more of the load? He’s been answering this question ever since. Markus holds a PhD in plant biochemistry from Durham University. He was previously a research associate in synthetic biology at University College London and a biotransformation scientist at Novacta Biosystems.
Got a Question for Markus Gershater, PhD?
Get in touch using the contact form linked here and we’ll get back to you shortly